Post-traumatic stress disorder adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From February 2004 to June 2026, FDA received 6,611 adverse event reports that record the MedDRA preferred term Post-traumatic stress disorder. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 381 reports in the 12 months to June 2026 and 373 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 1,124 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 381 (under 0.1%) record this term. Reports for patients aged 18 to 44 were 22.3% of the reports that record this term and 12.3% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 118 drug pages with 25 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Post-traumatic stress disorder name as a suspect product, in order of name
Drug	Class	Reports with this term
Abilify	Atypical antipsychotic	64
Accutane	Retinoid	26
Acetaminophen		25
Acetaminophen and codeine	Opioid agonist	38
Acetaminophen Hydrocodone Bitartrate		72
Acetaminophen Oxycodone Hydrochloride		239
Acetaminophen Oxycodone Hydrochloride Oxycodone Terephthalate		51
Acetylsalicylic Acid		29
Actemra	Interleukin-6 receptor antagonist	33
Adderall	Central nervous system stimulant	31
Aspirin	Nonsteroidal anti-inflammatory drug	113
Avonex	Interferon beta	41
Benadryl	Histamine-1 receptor antagonist	49
Buprenorphine	Partial opioid agonist	82
Buprenorphine hydrochloride	Partial opioid agonist	33
Buprenorphine Transdermal Patch		78
Butrans	Partial opioid agonist	88
Butylscopolamine bromide		38
Cetirizine	Histamine-1 receptor antagonist	35
Cetirizine hydrochloride	Histamine-1 receptor antagonist	78
Chantix	Partial cholinergic nicotinic agonist	127
Ciprofloxacin	Fluoroquinolone antibacterial	51
Citalopram	Serotonin reuptake inhibitor	29
Clonazepam	Benzodiazepine	78
Cocodamol		34
Cosentyx	Interleukin-17A antagonist	28
Cymbalta		96
Diazepam	Benzodiazepine	42
Dilaudid	Opioid agonist	312
Diphenhydramine	Histamine-1 receptor antagonist	27
Diphenhydramine hydrochloride	Histamine-1 receptor antagonist	78
Docetaxel	Microtubule inhibitor	51
Duloxetine	Serotonin and norepinephrine reuptake inhibitor	46
Dupixent	Interleukin-4 receptor alpha antagonist	44
Enbrel	Tumor necrosis factor blocker	161
Endocet	Opioid agonist	58
Entresto	Angiotensin 2 receptor blocker	32
Esomeprazole	Proton pump inhibitor	48
Esomeprazole magnesium	Proton pump inhibitor	40
Esomeprazole Magnesium Naproxen		37
Fentanyl	Opioid agonist	85
Fentanyl citrate	Opioid agonist	31
Fosamax	Bisphosphonate	57
Gabapentin	Anti-epileptic agent	55
Heroin		96
Humira		188
Hydrocodone bitartrate	Opioid agonist	63
Hydrocodone bitartrate and acetaminophen	Opioid agonist	518
Hydromorphone		76
Hydromorphone hydrochloride	Opioid agonist	73
Hydromorphone Tablet		26
Hydromorphone Tablets		85
Hysingla ER	Opioid agonist	26
Klonopin	Benzodiazepine	40
Latuda	Atypical antipsychotic	39
Lexapro	Serotonin reuptake inhibitor	31
Lorazepam	Benzodiazepine	28
Lortab		37
Lyrica		116
Methadone	Opioid agonist	70
Methotrexate	Folate analog metabolic inhibitor	31
Mirena	Progestin	30
Morphine sulfate	Opioid agonist	356
MS Contin	Opioid agonist	231
Msir		25
Naproxen	Nonsteroidal anti-inflammatory drug	58
Neurontin		26
Nexium	Proton pump inhibitor	88
Norco	Opioid agonist	60
Nuvaring	Estrogen	53
Ocrevus	CD20-directed cytolytic antibody	34
Omeprazole	Proton pump inhibitor	39
Opana		51
Opana Er		28
Oxycodone	Opioid agonist	78
Oxycodone and acetaminophen	Opioid agonist	349
Oxycodone hydrochloride	Opioid agonist	664
OxyContin	Opioid agonist	637
Oxyfast		39
Oxyir		69
Oxymorphone hydrochloride	Opioid agonist	30
Ozempic	GLP-1 receptor agonist	34
Pantoprazole	Proton pump inhibitor	27
ParaGard T 380A	Copper-containing intrauterine device	122
Percocet	Opioid agonist	306
Prednisone	Corticosteroid	75
Pregabalin		72
Prilosec	Proton pump inhibitor	34
Risperdal	Atypical antipsychotic	33
Rituxan	CD20-directed cytolytic antibody	50
Rituximab	CD20-directed cytolytic antibody	93
Ryzolt		33
Senna		28
Seroquel	Atypical antipsychotic	201
Sertraline	Serotonin reuptake inhibitor	66
Singulair	Leukotriene receptor antagonist	60
Skyrizi	Interleukin-23 antagonist	25
Spravato		45
Suboxone	Opioid antagonist	92
Tecfidera		37
Tiotropium bromide	Anticholinergic	47
Tramadol		269
Tramadol Cr Tablets		47
Tramadol hydrochloride	Opioid agonist	176
Trulicity	GLP-1 receptor agonist	31
Truvada	Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	29
Tysabri	Integrin receptor antagonist	76
Valium	Benzodiazepine	34
Vicodin		148
Vioxx		119
Xanax	Benzodiazepine	76
Xeljanz	Janus kinase inhibitor	43
Xyrem	Central nervous system depressant	284
Xywav	Central nervous system depressant	54
Yasmin		26
Yaz		44
Zoloft	Serotonin reuptake inhibitor	59
Zyprexa	Atypical antipsychotic	33

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 50 pharmacologic classes with 25 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Post-traumatic stress disorder name, in order of name
Class	Reports with this term
5-alpha reductase inhibitor	32
Aminoketone	31
Angiotensin 2 receptor blocker	46
Angiotensin converting enzyme inhibitor	27
Anti-epileptic agent	125
Anti-IgE	27
Anticholinergic	53
Atypical antipsychotic	505
Benzodiazepine	362
beta-Adrenergic blocker	29
beta2-Adrenergic agonist	56
Bisphosphonate	73
CD20-directed cytolytic antibody	196
Central nervous system depressant	340
Central nervous system stimulant	60
Copper-containing intrauterine device	122
Corticosteroid	183
Estrogen	61
Expectorant	25
Fluoroquinolone antibacterial	59
Folate analog metabolic inhibitor	41
GLP-1 receptor agonist	101
Histamine-1 receptor antagonist	306
HMG-CoA reductase inhibitor	37
Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	45
Insulin analog	39
Integrin receptor antagonist	103
Interferon beta	59
Interleukin-17A antagonist	28
Interleukin-23 antagonist	25
Interleukin-4 receptor alpha antagonist	44
Interleukin-5 antagonist	27
Interleukin-6 receptor antagonist	35
Janus kinase inhibitor	65
Leukotriene receptor antagonist	95
Microtubule inhibitor	51
Muscle relaxant	28
Nonsteroidal anti-inflammatory drug	230
Opioid agonist	4,256
Opioid antagonist	94
Osmotic laxative	30
Partial cholinergic nicotinic agonist	130
Partial opioid agonist	225
Phosphodiesterase 5 inhibitor	29
Progestin	40
Proton pump inhibitor	372
Retinoid	26
Serotonin and norepinephrine reuptake inhibitor	146
Serotonin reuptake inhibitor	329
Tumor necrosis factor blocker	193

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Post-traumatic stress disorder, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Post-traumatic stress disorder
Age	Reports	Share
Under 2	7	0.1%
2 to 11	44	0.7%
12 to 17	74	1.1%
18 to 44	1,473	22.3%
45 to 64	1,433	21.7%
65 to 74	278	4.2%
75 and over	92	1.4%
Age not given	3,210	48.6%

Sex of the patient in the reports that record Post-traumatic stress disorder
Sex	Reports	Share
Female	3,939	59.6%
Male	2,244	33.9%
Unknown or not given	428	6.5%

Age and sex are as the report gives them. 79.9% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Post-traumatic stress disorder: adverse event reports that record this term. https://reportedreactions.com/reaction/post-traumatic-stress-disorder/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Post-traumatic stress disorder mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page